HomeBUSINESS
BUSINESS

Astellas to Launch 3-Way Copromotion Scheme for Kiklin
(Oct.3.2017)

Astellas Pharma said on October 2 that it will begin a three-way scheme to copromote its hyperphosphatemia treatment Kiklin (bixalomer) in Japan from this month by adding cardiovascular specialist Toa Eiyo to its original arrangement with Sanwa Kagaku Kenkyusho ...
(LOG IN FOR FULL STORY)

News Calendar